Minakem Generic APIs Minakem Generic APIs

X

Find Hexahydroazepine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)
594
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Hexahydroazepine
Also known as: Azepane, 111-49-9, Hexahydroazepine, Perhydroazepine, Homopiperidine, Hexamethylenimine
Molecular Formula
C6H13N
Molecular Weight
99.17  g/mol
InChI Key
ZSIQJIWKELUFRJ-UHFFFAOYSA-N
FDA UNII
CZD076G73R

1 2D Structure

Hexahydroazepine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
azepane
2.1.2 InChI
InChI=1S/C6H13N/c1-2-4-6-7-5-3-1/h7H,1-6H2
2.1.3 InChI Key
ZSIQJIWKELUFRJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CCCNCC1
2.2 Other Identifiers
2.2.1 UNII
CZD076G73R
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Hexahydroazepine

2. Hexahydroazepine Hydrochloride

3. Perhydroazepine

2.3.2 Depositor-Supplied Synonyms

1. Azepane

2. 111-49-9

3. Hexahydroazepine

4. Perhydroazepine

5. Homopiperidine

6. Hexamethylenimine

7. Hexahydro-1h-azepine

8. 1h-azepine, Hexahydro-

9. Azacycloheptane

10. 1-azacycloheptane

11. Azepan

12. Cyclohexamethylenimine

13. Hexamethylene Imine

14. Azepine, Hexahydro-

15. Nsc 16236

16. Mfcd00006934

17. Czd076g73r

18. G 0

19. Chebi:32616

20. Nsc-16236

21. Dsstox_cid_6879

22. Dsstox_rid_78234

23. Dsstox_gsid_26879

24. Cycloheptane, 1-aza-

25. Cas-111-49-9

26. Hsdb 562

27. Einecs 203-875-9

28. Un2493

29. Brn 0001084

30. Unii-czd076g73r

31. Cp 18407

32. Ai3-26610

33. Ccris 8886

34. Azepane #

35. Hexamethyleneimine, 99%

36. Wln: T7mtj

37. Hexamethylene Imine (hmi)

38. Ec 203-875-9

39. 5-20-04-00003 (beilstein Handbook Reference)

40. Chembl1375444

41. Dtxsid1026879

42. Hexamethyleneimine [hsdb]

43. 2,3,4,5,6,7-hexahydroazepine

44. Act03374

45. Cs-b0958

46. Nsc16236

47. Str01425

48. Zinc3636476

49. Tox21_201482

50. Tox21_303304

51. Stl124104

52. Akos000119078

53. Un 2493

54. 2,3,4,5,6,7-hexahydro-1h-azepine

55. Ncgc00091040-01

56. Ncgc00091040-02

57. Ncgc00257117-01

58. Ncgc00259033-01

59. Bp-30036

60. H0092

61. D77224

62. Hexamethyleneimine [un2493] [flammable Liquid]

63. Q421530

64. J-002592

65. J-521455

66. Z57127566

67. F2190-0324

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 99.17 g/mol
Molecular Formula C6H13N
XLogP31.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count0
Exact Mass99.104799419 g/mol
Monoisotopic Mass99.104799419 g/mol
Topological Polar Surface Area12 Ų
Heavy Atom Count7
Formal Charge0
Complexity37.4
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 Metabolism/Metabolites

HEXAMETHYLENEIMINE WAS FOUND TO BE A URINARY METABOLITE OF THE CARCINOGEN N-NITROSOHEXAMETHYLENEIMINE IN MALE RATS.

GRANDJEAN CJ; METABOLISM OF N-NITROSOHEXAMETHYLENEIMINE; J NATL CANCER INST 57(1) 181 (1976)


HEXAMETHYLENIMINE WAS FOUND TO BE A URINARY METABOLITE OF PIVMECILLINAM IN HUMANS.

HATTORI M ET AL; METABOLITES OF PIVMECILLINAM IN HUMAN URINE; CHEMOTHERAPY (TOKYO) 25(1) 123 (1977)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY